BRCA2 and neoplasm: In the cisplatin-sensitive pancreatic ductal adenocarcinoma (PDA) BRCA2 mutant mouse model, the alteration of tumor volume after treated with cisplatin showed disease stabilization or frank regression was accompanied by decreased tumor stiffness, indicating the successful response of chemotherapy was related to decreased tumor stiffness in this animal model [68].